Latest cloning Stories
Connie K. Ho for redOrbit.com – Your Universe Online Researchers from the Columbia University Medical Center (CUMC) and the New York Stem Cell Foundation (NYSCF) have been able to create a new technique that limits inherited disorders in children. The ability of scientists to transfer the nucleus of a cell from one human egg cell to another was considered an important achievement, and results of the study were recently published in the online edition of Nature. In particular, the...
A new study published in Nature shows how mitochondrial disease may be prevented NEW YORK, Dec. 19, 2012 /PRNewswire-USNewswire/ -- A joint team of scientists from The New York Stem Cell Foundation (NYSCF) Laboratory and Columbia University Medical Center (CUMC) has developed a technique that may prevent the inheritance of mitochondrial diseases in children. The study is published online today in Nature. Dieter Egli, PhD, and Daniel Paull, PhD, of the NYSCF Laboratory with Mark...
Michael Harper for redOrbit.com – Your Universe Online The scientist who inspired the creation of Dolly the Sheep has now said human cloning is within our reach, bringing some hope of restoration to parents who have lost their child to a tragic death, reported the Telegraph. Nobel prize-winning Sir John Gurdon has been furthering the study of cloning since the 1950s and has had success cloning animals such as frogs. Now, he’s claiming we could begin to see fully functional human...
CHALFONT ST. GILES, UK and MADISON, Wis., Dec. 18, 2012 /PRNewswire/ -- GE Healthcare Life Sciences, a business unit of GE Healthcare (NYSE: GE) and Cellular Dynamics International (CDI), a leading commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells, announced today that GE Healthcare has licensed CDI to develop, manufacture and sell cellular assays and models derived from induced pluripotent stem (iPS) cells for use in drug discovery and...
University of Sheffield Randomly distributed sticky spots which are integral to the development of stem cells by maximizing adhesion and acting as internal scaffolding have been artificially recreated by experts from the University of Sheffield for the first time. Using synthetic foam type materials to mimic the natural process – known as the extracellular matrix or ECM – scientists, from the University of Sheffield and University of California San Diego, created the random...
EMERYVILLE, Calif., Dec. 13, 2012 /PRNewswire/ -- AllCells LLC, a leading life science industry provider of human hematologic tissue such as bone marrow, Leuko Paks, peripheral blood, healthy & diseased primary cells, and cell-based assay services, today announced plans to relocate its U.S operations to Alameda, California. The relocation will occur towards the end of Q1, 2013. Located at 1301 Harbor Bay Parkway, Alameda, CA, the new headquarters and production facility...
IPSWICH, Mass., Dec. 12, 2012 /PRNewswire/ -- New England Biolabs, Inc. (NEB) today released the Gibson Assembly Cloning Kit and online primer design tool, NEBuilder(TM), for the cloning of DNA fragments using the Gibson Assembly approach. This kit includes NEB's robust Gibson Assembly Master Mix and NEB 5-alpha competent E. coli for fragment assembly and transformation in less than two hours. (Photo: http://photos.prnewswire.com/prnh/20121212/NE28858) (Logo:...
Studies of stem cell biology and transplant approaches presented today at the 54th Annual Meeting of the American Society of Hematology (ASH) illustrate how the use of advanced modeling techniques is optimizing stem cells to treat patients with blood disorders, as well as the potential of enhanced treatment strategies to improve the success rate of hematopoietic stem cell (HSC) transplantation for these patients. Hematopoietic stem cell transplantation is effectively used today as a form...
ATLANTA, Dec. 9, 2012 /PRNewswire-USNewswire/ -- Studies of stem cell biology and transplant approaches presented today at the 54th Annual Meeting of the American Society of Hematology (ASH) illustrate how the use of advanced modeling techniques is optimizing stem cells to treat patients with blood disorders, as well as the potential of enhanced treatment strategies to improve the success rate of hematopoietic stem cell (HSC) transplantation for these patients. Hematopoietic stem...
HONG KONG, Dec. 6, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE:CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that one of its non-wholly owned subsidiaries, Favorable Fort Limited ("Favorable Fort"), has entered into a definitive agreement with Cordlife Services (S) Pte. Ltd., a subsidiary of the Company's strategic affiliate, Cordlife Limited (CBB.AU) ("Cordlife"), a cord blood and tissue banking...
